Table 3.

Serum AFP and serum sTLR4 levels of the three studied groups

Parameter	Control (n = 50)	Patients with hepatitis C without HCC (n = 50)	Patients with HCV-related HCC (n = 50)	Test of sig.	p-value
AFP (ng/ml), mean ±SD	2.73 ±1.14	7.02 ±2.99	289.89 ±691.26	H = 102.955*	< 0.001*
Serum sTLR4 (pg/ml), mean ±SD	1170.38 ±159.42	1561.4 ±532.0	4436.1 ±7089.8	H = 104.742*	< 0.001*
Sig. bet. grps	p1 < 0.001*, p2 < 0.001*, p3 < 0.05*

AFP – alfa-fetoprotein, H – Kruskal Wallis test, Pairwise comparison bet. each 2 groups was done using Post Hoc Test, p – p-value for comparing between the studied groups, p₁ – p-value for comparing between control and HCV, p₂ – p-value for comparing between the control and HCC, p₃ – p-value for comparing between the HCV and HCC, ^* statistically significant at p ≤ 0.05